Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Provision of outsourced development services on a global basis to the pharmaceutical, biotechnology8.28B100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
US2.99B36.05%
Ireland2.79B33.73%
Rest of Europe1.56B18.85%
Other942.64M11.38%